Corient Private Wealth LLC Decreases Stock Position in CVS Health Corporation $CVS

Corient Private Wealth LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVSFree Report) by 3.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 378,994 shares of the pharmacy operator’s stock after selling 13,376 shares during the quarter. Corient Private Wealth LLC’s holdings in CVS Health were worth $26,143,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Brooklyn Investment Group grew its holdings in CVS Health by 373.8% during the 1st quarter. Brooklyn Investment Group now owns 4,657 shares of the pharmacy operator’s stock valued at $315,000 after buying an additional 3,674 shares during the last quarter. Aptus Capital Advisors LLC boosted its stake in shares of CVS Health by 3.4% during the first quarter. Aptus Capital Advisors LLC now owns 12,422 shares of the pharmacy operator’s stock valued at $842,000 after acquiring an additional 412 shares during the last quarter. Wellington Management Group LLP raised its stake in CVS Health by 83.2% in the 1st quarter. Wellington Management Group LLP now owns 403,365 shares of the pharmacy operator’s stock valued at $27,328,000 after purchasing an additional 183,232 shares during the last quarter. Legacy Financial Advisors Inc. purchased a new position in CVS Health in the 1st quarter valued at about $260,000. Finally, Berkshire Asset Management LLC PA acquired a new stake in shares of CVS Health during the 1st quarter worth about $236,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of a number of analyst reports. Sanford C. Bernstein boosted their price objective on shares of CVS Health from $86.00 to $87.00 and gave the company a “market perform” rating in a research report on Friday, December 12th. Jefferies Financial Group boosted their price target on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Raymond James Financial raised their price objective on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. TD Cowen lifted their price objective on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Finally, Truist Financial set a $100.00 target price on CVS Health in a research report on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $94.67.

Get Our Latest Analysis on CVS

CVS Health Trading Down 0.4%

Shares of CVS opened at $77.95 on Thursday. The stock’s fifty day simple moving average is $79.08 and its 200 day simple moving average is $72.24. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $98.95 billion, a P/E ratio of 205.14, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.